Thursday, August 8, 2013

PHA President on New Drug for PAH & CTEPH

PHA President on New Drug for PAH & CTEPH PHA's President Rino Aldrighetti was at the meeting earlier this week where a FDA committee reviewed a possible new drug for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Read Rino's blog for a front row seat 

No comments: